Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis
about
Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistancePharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimenPharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women.Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance.Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review.In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.Sensorineural hearing loss due to Toxoplasma gondii in children: a case-control study.
P2860
Q28472222-EADBFFB9-146A-4245-9418-2661B1004C57Q34737758-421E24BE-16C0-49BC-B95A-9A51FE1BD761Q36536401-33F7DFAA-34F9-4DBF-8C6E-1F0C8DD9FC67Q37392749-C3E76091-F282-4FD8-A15C-8EE1C750C6E0Q38838930-48896280-0524-41A5-BA8B-4C5500533E0EQ40063101-4AFCABA8-3AE8-48C5-B1C0-A2D0B69FCE08Q41831157-9AC4D551-8495-4E4B-9639-D0205ECB7666Q44848336-51468729-CEB8-4857-AB7C-1A4361BA1EBF
P2860
Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Population pharmacokinetics of ...... with congenital toxoplasmosis
@ast
Population pharmacokinetics of ...... with congenital toxoplasmosis
@en
type
label
Population pharmacokinetics of ...... with congenital toxoplasmosis
@ast
Population pharmacokinetics of ...... with congenital toxoplasmosis
@en
prefLabel
Population pharmacokinetics of ...... with congenital toxoplasmosis
@ast
Population pharmacokinetics of ...... with congenital toxoplasmosis
@en
P2093
P2860
P921
P1476
Population pharmacokinetics of ...... with congenital toxoplasmosis
@en
P2093
Jaussaud R
P2860
P304
P356
10.1111/J.1365-2125.2004.02077.X
P407
P577
2004-06-01T00:00:00Z